Financhill
Back

ResMed Vs. Perspective Therapeutics Industry Stock Comparison

Sell
50

RSMDF
ResMed

Last Price:
17.70
Seasonality Move:
16.02%
Sell
30

CATX
Perspective Therapeutics

Last Price:
7.88
Seasonality Move:
40.67%
Sell
50
ResMed (RSMDF) is a Sell

Is ResMed a Buy, Sell or Hold?

  • The current ResMed [RSMDF] share price is $17.70. The Score for RSMDF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RSMDF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $7.88. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RSMDF Stock Price Chart

What is ResMed's stock price today?

  • The ResMed share price today is $17.70
    The current trend is relatively stagnant and RSMDF is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $7.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

RSMDF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 3.3 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.7 - 17.7) Sell
Bollinger Bands (100): (17.7 - 17.7) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 19.21 Sell
Chaikin Money Flow: -1814221 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.47 - 12.81) Sell
Bollinger Bands (100): (11.15 - 14.37) Sell

RSMDF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.7 Sell
20-day SMA: 17.7 Sell
50-day SMA: 17.7 Sell
200-day SMA: 18.05 Sell
8-day EMA: 17.7 Sell
20-day EMA: 17.7 Sell
50-day EMA: 17.7 Sell
200-day EMA: 17.82 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.48 Sell
20-day SMA: 11.39 Sell
50-day SMA: 12.61 Sell
200-day SMA: 12.8 Sell
8-day EMA: 10.03 Sell
20-day EMA: 11.13 Sell
50-day EMA: 12.15 Sell
200-day EMA: 11.67 Sell

ResMed Earnings Growth & RSMDF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.33 per share.

ResMed Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):